Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bexagliflozin vs dapagliflozin in type 2 diabetes mellitus inadequately controlled on metformin
CTR20210322Phase 3Completed
- Sponsor
- Theracos Bio
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bexagliflozin in type 2 diabetes mellitus (T2DM), sponsored by Theracos Bio. Started Feb 2021; status: completed.
02
Drugs
bexagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20210322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210322.